- $1.19bn
- $872.13m
- $276.28m
- 88
- 15
- 51
- 50
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 68.4 | 102 | 167 | 238 | 276 |
Cost of Revenue | |||||
Gross Profit | 46.3 | 72 | 115 | 168 | 204 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 103 | 126 | 241 | 335 | 379 |
Operating Profit | -34.3 | -24 | -74.1 | -96.6 | -103 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -32.9 | -23.7 | -74 | -92.6 | -89.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -33.5 | -24.6 | -75 | -93.4 | -90.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -33.5 | -24.6 | -75 | -93.4 | -90.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -33.5 | -24.6 | -75 | -93.4 | -90.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.327 | -0.24 | -0.682 | -0.838 | -0.727 |
Dividends per Share |